Загрузка...
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is effective in the treatment of human chronic lymphocytic leukaemia and mantle cell lymphoma. Recent data have shown that ibrutinib also blocks IgE‐dependent activation and histamine release in human basophils (BAs) and mast cells (MCs). T...
Сохранить в:
| Опубликовано в: : | Vet Comp Oncol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Publishing Ltd
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900099/ https://ncbi.nlm.nih.gov/pubmed/31286638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12520 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|